Nanopharmaceutical : A Comprehensive Review

Museb shaikh Mukhtar*,Khalifa Mahmadasif Y, Pathan Ayyaj Magbul, Shaikh Faisal, Shaikh Aman, MD Moiz, Shaikh Arbaj.

JIIU’s Ali Allana College of Pharmacy Akkalkuwa, Dist-Nandurbar -425415, Maharashtra, India

*Correspondence: musebshaikh7613@gmail.com ; Tel.: (+91 8600314907)

INTRODUCTION

The Greek prefix "nano" means "dwarf" or "small," and one billionth of a meter is equal to 10^-9 m = 0.000000001. Distinguishing between nanotechnology and nanoscience is crucial. The study of molecules and structures on nanoscale. The field of technology known as nanotechnology uses nanoscale sizes, which vary from 1 to 100 nm, in practical applications such as tools. In contrast, the radius of the DNA double helix is 1 nm, whereas the diameter of a single human hair is 60,000 nm. Conversations between the Greeks and Democritus in the fifth century B.C. about whether matter is continuous and therefore infinitely divided into smaller pieces or is made up of tiny, indivisible, and indestructible components known as atoms are where nanoscience got its start. Significant improvements in human life and health care have been made possible by pharmaceutical nanotechnology. While nanoscale materials are commonly utilized in other industries like electronics and optics, biomaterials used in this field are largely designed to improve drug delivery systems, imaging, and diagnostic technologies.⁸

A pharmaceutical preparation that contains nanoparticles and is meant to be used internally or externally on humans for medicinal, diagnostic, and health-promoting purposes is known as a nanopharmaceutical. Materials with particle sizes in at least one dimension between 1 and 100 nm are often referred to as nanomaterials. But if a material exhibits physical, chemical, or biological properties or activity that may be linked to its dimensions outside of the nanoscale range up to 1000 nm, it is also deserving of being classified as a nanomaterial. Therefore, any medication that contains this type of material must be classified as nanopharmaceutical.⁴

The pharmacokinetic, biodistribution, and toxicokinetic parameters of conventional/traditional drugs may be significantly altered by the alteration of the substance into the nanoscale associated with drug delivery. This raises a number of concerns regarding the efficacy, safety, and quality of the nanopharmaceutical products.³
The science and engineering that goes into designing, synthesizing, characterizing, and using materials and devices whose smaller functional organization in at least one dimension is on the nanoscale scale is another way to define it.²
Nanoparticles are composed of three layers because they are not simple molecules in and of themselves: (a) the surface layer, which can be functionalized with various small molecules, metal ions, surfactants, and polymers; (b) the shell layer, which is chemically different from the core in some way; and (c) the core, which is essentially the middle portion of the NP and usually refers to the NP itself.¹⁶

Nanoparticles are considered to be the basic building block of nanotechnology. Nanoparticle production methods are constantly being researched and enhanced. Nature contains a wide variety of nanoparticles, each with remarkable applications in a particular field. Nanoparticles include things like nanospheres and nanocapsules. Nanospheres are a matrix system that evenly distributes medications, whereas nanocapsules include a pharmaceutical encased in a special polymeric membrane.¹⁰

History

The Romans showcased one of the most intriguing applications of nanotechnology in antiquity in the fourth century AD, suggesting that humans had been using nanoparticles and structures for quite some time. Preserved in the collection of the British Museum, the Lycurgus cup is one of the greatest triumphs of the ancient glass industry. It is the oldest and most well-known dichroic glass figure. Dichroic glass refers to two types of glass whose colors change depending on the light. This suggests that the Cup has two tones: green when viewed directly and reddish-purple when viewed through the glass.

Figure 1. The Lycurgus Cup (British Museum)⁸

To find out more about the dichroism phenomena, scientists used Transmission Electron Microscopy (TEM) to investigate the cup in 1990. The observed dichroism, or two hues, is attributed to the existence of nanoparticles with a diameter of between 50 and 100 nm. Based on X-ray analysis, these nanoparticles are silver-gold (Ag-Au) alloys with a copper (Cu) component of around 10% and an Ag: Au ratio of about 7:3. The crimson coloration of the Au nanoparticles is caused by light absorption at 520 nm. Ag nanoparticles larger than 40 nm are colloidal dispersions that scatter light to give the green appearance, whereas larger particles absorb light to produce the reddish-purple color. The Lycurgus cup is among the first instances of a manufactured nanomaterial. The initial discoveries associated with the development of nanomedicine were made at ETH Zurich in the late 1960s. Over the past few decades, there has been a significant technological and industrial advancement in nanomedicine. It has been distinguished by a few noteworthy projects that have paved the way for its expansion.⁸

Types of Nanoparticles:

Fig 2. Element of nanotechnology, which are utilized in therapeutic application.¹⁸

Nano-structured and nanocrystalline are the two main subcategories of nanomaterials. Lipid-based nanoparticles as well as non-polymer and polymer-based nanoparticles can all be classified as nano-structured materials. Polymer-based nanoparticles include dendrimers, micelles, nanogels, protein nanoparticles, and drug conjugates. Non-polymeric nanoparticles include silica-based nanoparticles, metallic nanoparticles, quantum dots, carbon nanotubes, and nanodiamonds. Liposomes and solid lipid nanoparticles are two kinds of lipid-based nanoparticles. Most of the nanoparticles with lipid or polymer-based components that have been clinically approved for use in therapy thus far. Aside from nano-structured particles based on polymers, non-polymers, or lipids, certain therapeutic applications also employ nanocrystalline particles created by combining medicinal ingredients in a crystalline form.¹⁸

Nano-Structured Particles:

Polymer-Based Particles:

v  Dendrimers:

Dendrimers are polymers consisting of branching repeating units and exterior functional groups extending from a central core. These functional groups, which can be neutral, cationic, or anionic terminals, can alter the structure's chemical and physical properties in addition to its overall composition. Dendrimers are extremely bioavailable and biodegradable because therapeutic compounds can be bonded to the surface groups or encapsulated within the interior space. It has been observed that dendrimer conjugates containing saccharides or peptides exhibit superior antibacterial, antiprion, and antiviral properties, along with enhanced solubility and stability upon absorption of therapeutic agents. Dendrimers are potential particulate systems for biomedical applications, including drug administration and imaging, because to their transformable characteristics. Dendriplexes, also called polyamidoaminedendrimer DNA complexes, have been investigated as gene delivery vectors and show potential for improving medication efficacy, enabling targeted drug delivery, and enabling successive gene expression.¹⁸

v  Nanoparticles:

Synthetic or natural polymer-based nanoparticles provide an alternative approach for therapeutic applications because of their unique properties such as biocompatibility, non-immunogenicity, non-toxicity, and biodegradability. The use of polyester forms reduces the immunogenicity and toxicity of synthetic polymers such as polycaprolactone (PCL), polylactic acid (PLA), and related monomers. Compared to conventional approaches, natural polymer-based nanoparticles including chitosan, gelatin, albumin, and alginate appear to be able to overcome toxicity concerns and considerably improve the efficacy of therapeutic drugs. The matrix system, in which the matrix is uniformly dispersed, is thought to consist of polymeric nanoparticles. Depending on their constitution, they fall into one of two categories: nanospheres or nanocapsules. Therapeutic ingredients are quickly diffused throughout or inside the polymer matrix in nanospheres as opposed to being encapsulated in a distinct polymer membrane as in nanocapsules. The diversity of polymeric nanoparticle manufacturing methodologies enables for targeted delivery of higher quantities of medications to the designated location, hence providing more control over the release properties of therapeutic drugs. Moreover, the specificity of therapeutic drugs in the targeted tissue can be enhanced by simply altering and functionalizing the surface of polymeric nanoparticles with a particular recognition ligand.¹⁸

v  Micelles:

Micelles are amphiphilic surfactant molecules that are formed when lipids and other amphiphilic molecules come together. Micelles self-assemble and spontaneously aggregate to form spherical vesicles with a hydrophobic core and a hydrophilic outer monolayer in aqueous environments. Consequently, hydrophobic medications may be used. Micellar particles has unique properties that enable the solubility of hydrophobic medicines, hence boosting their bioavailability. The sizes of micelles range from 10 to 100 nm. Among their many uses are as drug delivery agents, contrast agents, therapeutic agents, and imaging agents.¹⁸

v  Drug Conjugates:

Polymers are commonly conjugated with low molecular weight medications, especially in the treatment of cancer. This conjugation increases the molecular weight of the drugs overall and induces the pharmacokinetic distribution in the cells. Polymer-drug conjugates show excellent solubility and stability, and they also encourage an EPR effect in malignant cells. It has been demonstrated that covalently conjugated polymer-drugs are more dependable for prolonged drug release and larger drug capacity. Certain polymeric drug conjugates use chemical bonds between the polymer and the drug to react to changes in pH. The pH sensitivity of the nanoparticles is used to regulate drug release in the acidic environment of the tumor location. Moreover, polymeric drug conjugates have been found to enhance the medication's bioavailability, as seen by the doxorubicin and paclitaxel combination therapy.¹⁸

v  Protein Nanoparticles:

The genetic material of viruses is enclosed by the capsid proteins, which function as incredibly effective and organic transport mechanisms. "Virus-like particles" (VLPs) are a class of protein nanoparticles that lack viral genetic material but morphologically evoke virus-isolated entities. Moreover, caged proteins (CP), a class of self-assembled protein nanostructures, are described as morphologically similar to viruses but not actually viruses. VLPs and CPs are excellent nano-carrier systems for the creation of cancer vaccines because they can trigger immune responses specific to specific antigens on cancer cells. Moreover, protein polymers—isolated proteins derived from plants or animals—have the ability to self-assemble into protein nanoparticles. Collagen, gelatin, silk, albumin, elastin, and soy are a few examples of them. Protein polymers can be genetically altered to self-assemble into efficient drug delivery systems, similar to polymer-based nanoparticles. Abraxane®, a drug in the form of protein nanoparticles that allows albumin to distribute paclitaxel, was approved by the FDA. However, the discovery of a VLP-based HIV vaccine sped up research on clinically beneficial protein nanoparticles and produced important breakthroughs.¹⁸

v  Nanogels:

Gels are networks of non-fluid polymers or colloids that swell when they come into contact with liquid. Nanogels are gel particles with a diameter of less than 100 nm that have characteristics similar to conventional gels, according to the International Union for Pure and Applied Chemistry. Natural or artificial polymers that have undergone physical or chemical cross-linking provide nanogels their capacity to expand, their variable size, and their high water content. The first nanogel self-assembled in water because of hydrophobic interactions. It was made by physically cross-linking amphiphilic polysaccharides with pullulans that contained cholesterol. Compared to earlier nano-carrier systems, nanogels have advantages including less early drug leakage, the capacity to encapsulate several therapeutic chemicals in one formulation, and simple mucosal or parental distribution. Biosensors, biochemical separation, cell culture, bio-catalysis, drug delivery, anticancer therapy, and other fields are among the many uses for nanogels. Interestingly, they are being studied in great detail for the administration of medications such as cytokines, nasal vaccines, immunizations, and nucleic acids, among others.¹⁸

Non-Polymeric Particles:

v  Carbon Nanotubes:

Carbon nanotubes are cylindrical structures made of rolled-up sheets with a single layer of carbon atoms (graphene). These tubes are made of linked nanotubes stacked in concentric layers and can be single-walled or multi-walled structures. Because of their large exterior surface area, carbon nanotubes have significant loading capabilities when used as drug carriers. Moreover, carbon tubes are desirable for uses like biological sensors and imaging contrast agents due to their unique optical, mechanical, and electrical properties.¹⁸

v  Nanodiamonds (NDs):

Nanodiamonds (NDs) are a type of carbon-based nanomaterial that have two distinct facets and a diameter less than 100 nm. They can have a variety of forms. ND is produced via a variety of processes, including as detonation, chemical vapor deposition (CVD), and high-pressure/high-temperature procedures. The most common and commonly used method for ND synthesis is the detonation method, which involves a controlled explosion on carbon-containing precursors in a confined chamber. Due to the NDs' structure and form, sp² carbon is frequently visible on the surface of NDs made using this technique. The CVD process yields high-quality films with few defects and is suitable for the deposition of NDs as thin films on various substrates. Among their special qualities are surface electrostatic characteristics, minimal cytotoxicity from a chemically inert core, less photo-bleaching from additional nitrogen defects, and the ability to immobilize different proteins for functionalization. Because of their unique characteristics, NDs are significant in biomedical applications such as medication delivery in cancer therapy, contact lens manufacturing, and magnetic resonance imaging (MRI). When NDs and gadolinium [Gd] are used together as a contrast agent in magnetic resonance imaging (MRI), the result is a noticeably higher signal than when Gd-based contrast agents are used alone.¹⁸

v  Metallic Nanoparticles

Metal-based nanoparticles are synthesized to nanometric sizes using either constructive or destructive processes. Almost any metal can be made into nanoparticles; widely used metals include aluminum, cadmium, cobalt, copper, gold, iron, lead, silver, and zinc. The characteristics of nanoparticles are unique and include sizes between 10 and 100 nm as well as a range of surface features such as pore size, high surface-to-volume ratio, surface charge density, crystalline structures, spherical forms, color, reactivity, and sensitivity. The basis for the synthesis of metal nanoparticles is metal precursors. These nanoparticles have special optoelectrical properties because of limited surface plasmon resonance (SPR). Interestingly, in the solar electromagnetic spectrum, noble metals and alkali nanoparticles such as Cu, Au, and Ag have a strong absorption band. The exact synthesis of metal nanoparticles with regulated size and form is crucial in the field of advanced materials.⁹

v  Quantum Dots:

Quantum dots (QDs) are fluorescent semiconductor nanocrystals that range in size from 1 to 100 nm. They show promise in a number of biomedical applications, such as cellular imaging and medication administration. The shell-core structure of quantum dots is composed of elements from either the II-VI or III-V groups of the periodic table. Medical imaging has found use for quantum dots due to their distinct optical properties and the exceptional brightness and stability that come from their small size.¹⁸

v  Silica-Based Nanoparticles:

Silica-made nanoparticulate materials (SiNPs) are a desirable option for medication and cell delivery among various nanoparticulate materials. Because of their mesoporous nature, they have been found to be useful for drug and gene encapsulations, with a preference for loading biomacromolecules with biocompatibility, retention flexibility, nontoxicity, and larger quantities with low preparation costs. They have also been found to be useful in drug delivery and distribution, imaging, and controlled release. Among the most often employed nanoentities for a variety of biomedical applications are SiNPs. Large pores with high surface areas were present in nanoporous silica materials, which allowed drugs to accumulate in sufficient concentrations at the site and absorb large amounts of the drug. This improved localized delivery for treatment and other purposes.In addition, the surface of SiNPs contains silanol groups, which allow for easy surface changes and accurate drug release control while also improving loading capacity.⁶

Lipid-Based Nanoparticles:

v  Liposomes:

Liposomes are spherical vesicles made of lipid bilayers with particle sizes ranging from 30 nm to several microns. These adaptable architectures can include hydrophobic therapeutic compounds in the liposomal membrane layer and hydrophilic medicines in the aqueous phase. Liposomes are versatile because they may be made to change the properties of their surface by adding polymers, antibodies, or proteins. This makes it possible to incorporate crystalline metals and nucleic acids, among other macromolecular medications, into liposomes. Notably, the first FDA-approved nanomedicine is Poly (ethylene glycol) (PEG)ylated liposomal doxorubicin (Doxil®). It has demonstrated efficacy in the treatment of breast cancer by increasing the drug's concentration in malignant effusions without requiring a dose increase in overall.⁷

v  Exosomes:

Exosomes are naturally occurring particles that range in size from 30 to 150 nm and are secreted by different kinds of cells. They start life as endosomes. Similar to cell membranes, these lipid bilayer vesicles are present in body fluids like blood, urine, saliva, and breast milk. Exosomes, which are made up of proteins, glycolipids, RNA, DNA, and other components, are essential for intracellular communication. They have a critical role in physiological processes such as immunological response, neuronal transmission, and antigen presentation, especially in diseases including cancer, diabetes, cardiovascular disease, and inflammation. Notably, because they can be separated from a patient's physiological fluids, allogenic exosomes have an edge against immune system defences . This makes it easier to protect the cargo from quick clearance and improves the distribution of drugs to targeted places. Exosomes may be used as drug delivery vehicles in the treatment of autoimmune disorders and cancer, as biomarkers for cancer diagnosis, and even for tissue regeneration, according to recent studies.¹⁸

v  Solid Lipid Nanoparticles (SLN):

Solid lipid nanoparticles (SLNs) are a result of the emergence of lipids as an alternative carrier for polymeric nanoparticles, particularly for lipophilic pharmaceuticals. Introduced in 1991, SLNs offer a feasible alternative to typical colloidal carriers such emulsions, liposomes, and polymeric micro and nanoparticles. This system comprises spherical solid lipid particles within the nanometer range, distributed either in water or in an aqueous surfactant solution. SLNs are made up of a monolayer coating of phospholipids covering a solid hydrophobic core. These phospholipids' hydrophobic chains are embedded in the fat matrix, which offers the possibility of transferring hydrophilic or lipophilic medications or diagnostic materials.⁵

Nanocrystalline Particles:

With a crystallite size of only a few nanometers, nanocrystalline particles, also known as nanocrystals, are drug particles free of carriers. Formulations with nanocrystals, developed as an extremely economical method, are frequently used for drugs with poor water solubility, low bioavailability, and restricted absorption. Reducing the particle size is often a good way to increase the bioavailability of a drug, with the rate-limiting step being the dissolving velocity. The crystalline structure increases the total surface area and speeds up the pace of disintegration. This property improves solubility, which is important when the agent's therapeutic index is limited by problems with absorption. On the other hand, medications that need a quick start of action can be absorbed more quickly due to the quick breakdown of nanocrystalline particles. By altering the surface of the nanocrystal, one can achieve targeted or delayed release, which makes it easier to administer medications at lower doses and minimizes side effects.¹⁸

PREPARATION / SYNTHESIS:

Physical methods of nanoparticles synthesis:

In the past, physical methods such as heat, high-energy radiation, and mechanical pressure have been used to cause material to condense, evaporate, abrade, or melt in order to create nanoparticles. Physical techniques outperform chemical ones in terms of uniform nanoparticle distribution and the lack of solvent contamination in thin films. These methods produce reliably monodisperse nanoparticles without the use of solvents and employ a top-down methodology. Physical vapor deposition, high-energy ball milling, inert gas condensation, laser ablation, and laser pyrolysis are frequently used techniques for creating nanoparticles.¹⁰

Fig 3. Various techniques for synthesis of Nanoparticles.

Inert gas condensation (IGC):

This method is used to produce a wide variety of nanomaterials, including semiconductors, ceramics, composites, alloys, metallic, and metallic oxide nanoparticles, as well as intermetallic compounds. This method makes it easier to produce different-sized nanoparticles. Adjusting variables like temperature, inert gas injection, and chamber pressure can all be used to control the size of the created nanoparticles. By using inverse gas chromatography (IGC), size-controlled copper nanoparticles were produced. This technique was also used to create silver nanoparticles, where the morphology, size distribution, and crystallinity were greatly affected by the evaporation temperature and inert gas pressure. One particularly effective method for producing superior silver and platinum nanoparticles is inert gas condensation. Metallic dielectric multi-core-shell nanoparticles were created using the inert gas condensation technique. The method of inert gas condensation (IGC) is particularly useful for generating ultrafine nanoparticles.¹⁰

Laser ablation:

Laser beam ablation is used in the laser ablation (LA) process, often referred to as pulse laser deposition (PLD), to remove material from a solid surface. Particles from a solid source are evaporated using a powerful laser beam in the laser ablation process. Another distinct vacuum-based PVD method, called physical vapour deposition, or PLD, uses laser radiation to remove material from the target. The target's surfaces ionize, melt, and evaporate as a result of the intense laser pulses. It is important to emphasize that electron and ion species have a significant influence on the nucleation process, which results in the production of electrically charged laser ablation particles. AFM (atomic force microscopy) verified in 2005 that Ni-NPs were produced by PLD (pulsed laser deposition). The laser ablation technique was utilized to manufacture colloidal metallic nanoparticles of zinc. To create photoluminescent lead sulphide (PbS) nanoparticles in an amorphous SiO2 matrix on a Si substrate, researchers used pulse laser deposition. Silver nanoparticles were loaded onto a carbon fiber in situ while nitrogen was flowing through the use of spark ablation in gas (SAG). For the Ag nanoparticles formed on carbon fiber using SAG, studies were conducted on the effects of carrier gas flow rate and deposition period on particle size, dispersibility, and performance in the hydrogen evolution reaction in acidic circumstances. In a different investigation, Ag nanoparticles were deposited via PLD on nickel hydroxide nanosheet arrays in order to perform surface enhanced Raman scattering. When using laser ablation to create particles, the laser's wavelength was important. Although this process has several drawbacks, including high cost, low yield, and difficulties controlling nanomaterial morphology, it also has the potential to produce carbon nanotubes.¹⁰

Physical vapors deposition (PVD):

Physical vapor deposition is a thin-film coating and vaporization technique that involves the atomic-level transfer of materials, such as metals and alloys, from one source to another in a vapor state. Because physical vapor deposition (PVD) minimizes pollution formation throughout the process, it is in line with "green engineering," which is why this approach is called "physical". A variety of techniques used in the synthesis of thin material layers and nanoparticles are referred to as physical vapor deposition. Physical vapor deposition (PVD) coatings are frequently used to improve wear resistance, oxidation resistance, and hardness of metals. Sputtering is the most often used physical vapor deposition technique for the creation of nanoparticles. A vacuum environment is used in the PVD process of sputtering to deposit thin coatings and nanoparticles.¹⁰

Laser pyrolysis:

An economical and successful method for producing magnetic and affordable nanoparticles is laser pyrolysis. By breaking down a powerful CO2 laser, laser pyrolysis serves as a vapor phase synthesis method. Gaseous or liquid reactants are excited by this laser and quickly quenched afterward. This procedure involves spraying a salt solution into a sequence of reactors, where the solvent evaporates and raises the solute concentration of the droplets. The resulting particles are then dried and converted at high temperatures. Laser pyrolysis is scalable to large-scale production, but its application calls for expensive, specialized equipment. Notably, the production of several nanoparticles such as silicon carbide, silicon, molybdenum disulphide, and TiO/SiO2 nanoparticles has been made possible by laser pyrolysis. Numerous studies indicate that metals, oxides, carbides, nitrides, and composite nanoparticles may be produced using this technique. By using tetraethyl orthosilicate, silane, and titanium isopropoxide as precursor materials in the laser pyrolysis process, ceramic nanoparticles, such as silicon dioxide and titanium dioxide, can be synthesized for energy applications and the protection of cultural heritage. When it comes to creating nanoparticles from a variety of ternary composites, oxides, and non-oxides, laser pyrolysis techniques are quite versatile.¹⁰

High Energy Ball Milling (HEBM):

The process of ball milling is a basic technique that was used to make the first nanomaterials. Wet or dry grinding, ball-to-powder weight ratio, speed, time, kind of high-energy ball mill, and environment during milling.The milling medium have an effect on the energy transfer that takes place between the material and the balls during the milling process, which affects the morphological and physical characteristics of nanomaterials. Graphite nanoparticles, with a size range of 1 to 30 nm, were synthesized in an aqueous solution through the use of carbon black as a precursor and phosphate ester as a surfactant in high-energy ball milling. ZnO microcrystalline powder was used in High-Energy Ball Milling (HEBM) to create ZnO nanoparticles with a size of 30 nm. The HEBM technique that uses Dodecyl dimethylbetaine (BS-12) as a surfactant made it easier to extract pure calcium carbonate nanoparticles from cockle shells. Two methods were used to produce FePt nanoparticles using HEBM: the first required mixing and grinding elemental powders, and the second involved milling while hexane was used as a solvent and surfactants (oleyamine and oleic acid) were present. In 2013, researchers used HEBM to generate homogeneous lithium niobate nanoparticles by optimizing several milling parameters. In the recent past, HEBM has proven to be a powerful technique for producing nitrogen-doped carbon nanoparticles on a large scale for use in catalysis. In 2014, well-crystallized cobalt ferrite nanoparticles were prepared by researchers using microwave-assisted high-energy ball milling. Poly (methyl methacrylate), or PMMA, was combined with fumed silica nanoparticles by a high-energy ball milling procedure.¹⁰

Chemical methods of nanoparticles synthesis:

The chemical approach is used to create nanoparticles, and both organic and inorganic reducing agents are used. Reducing agents are essential to this process because they lower ions, which causes metal to assemble and then clump together to form oligomeric clusters, which in turn produces metallic colloidal particles. In order to guarantee the stabilization of scattered nanoparticles, protective agents must be incorporated during the synthesis of metal nanoparticles. By binding or effectively absorbing onto the surfaces of nanoparticles, these protective agents stop unwanted agglomeration. Polyethylene glycol (PEG), polymethylmethacrylate (PMMA), polyvinylpyrrolidone (PVP), and poly (methacrylic acid) (PMAA) are examples of protective agents that are frequently used. They play the vital role of keeping the nanoparticles from clumping together while they are being synthesized. Different chemical techniques are used to create nanoparticles; these techniques are categorized as bottom-up nanoparticle synthesis. These include the following techniques: salvo thermal synthesis, Sol-gel method, micro-emulsion technique, hydrothermal synthesis, polyol synthesis, microwave-assisted synthesis, plasma, and chemical vapor synthesis. All these methods support the bottom-up approach and enable the methodical and controlled synthesis of nanoparticles.¹⁰

Chemical Vapors Synthesis (CVS):

Chemical vapor precipitation (CVP), chemical vapor condensation (CVC), chemical vapor deposition (CVD), and chemical vapor reaction (CVR) are some of the acronyms for chemical vapor syntesis (CVS), a process used to deposit solid films from the vapor phase through chemical reactions that take place at very high temperatures. The deposition process is greatly influenced by temperature, reaction rate, and precursor concentration in the semiconductor industry, where this technology is widely used to produce pure and high performance thin films. Thin films with ultrafine particles are created during the CVD process under particular circumstances. Through synthesis techniques, the substrate is exposed to volatile precursors in three different states: solid, gas, and liquid. In the reactor, this causes the substrate to change into vapors under circumstances that need particle nucleation. When nanoparticles are created via the CVD process, more surface flaws are shown. Ni/NiO nanostructures have been synthesized via chemical vapor deposition from metal organic precursors (MOCVD). MOCVD has a number of benefits, including as its ease of use, equipment affordability, and the capacity to regulate particle production by adjusting process factors like reactor residence time, precursor concentration, or high-temperature reactor. MoS2 monolayers exhibit a lateral size augmentation that enables them to expand to a typical size of 20 m, even in the presence of nanometric bilayer islands and nanoparticle inclusion in CVD.¹⁰

Hydrothermal Synthesis:

Hydrothermal synthesis is a newly suggested technique for producing hydrophobic or hydrophilic magnetic nanoparticles with exact control over size and form. Batch hydrothermal systems or continuous hydrothermal systems can be used to perform this technique. The hydrothermal approach was successfully used to produce nanoparticles with a width of less than 10 nm while operating at 150°C. One simple and quick method for creating different material nanoparticles is hydrothermal synthesis. The hydrothermal technique's adaptability makes it possible to control the shape, composition, surface chemistry, size, and crystalline phase of the particles. A number of variables, including reaction temperature, pressure, solvent characteristics, aging period, additives, and solution composition, can be changed to accomplish this control. Hydrothermal synthesis can be carried out above or below the supercritical point of water, but it always requires a proper reactor or sealed reaction vessel to maintain temperature and pressure control during the reaction. Although monodisperse particles with high crystallinity can be produced using this synthesis process, scaling up may provide difficulties in some circumstances. However, this technique's most noteworthy benefit is its capacity to facilitate the inexpensive synthesis of a huge number of nanoparticles. A rapid and easy way to make nanoparticles of several materials, including ZnO, CdS, FeWO4, CoFe2O4, Zr, and Ag, is through hydrothermal synthesis. Inorganic nanoparticles have also been produced using hydrothermal or electrochemical processes.¹⁰

Microwave assisted synthesis:

Numerous nanoparticles have been produced with the help of microwave radiation. This method has been widely used to produce a variety of nanomaterials and has the remarkable benefit of not requiring long-term high-temperature calcination. Nanomaterial production may be carried out quickly and reliably with the use of microwave methods. The idea of "microwave dielectric heating," in which a material's ability to absorb and transform microwave energy into heat, is essential to the efficacy of microwave-enhanced chemistry. Recent research has demonstrated the great use of microwave heating in a variety of organic synthesis processes, demonstrating its accuracy and efficiency. It is remarkable that these effects are obtained by microwave heating without the need for interaction between the energy source and the reaction vessel. Researchers showed the effectiveness of microwave radiation in 2005 by producing suspensions of colloidal TiO2 nanoparticles in under five minutes. A key factor in these processes is microwave dielectric heating, a non-quantum mechanical phenomenon that causes sample volumetric heating. CuS nanoparticles can be produced with the use of microwave assistance and are well-known for their strong photocatalytic activity under ambient light. They work well in breaking down materials such as methyl orange, 4-chlorophenol, and methylene blue. Zinc oxide (ZnO) nanoparticles were created using a unique microwave-assisted method that included ascorbic acid and polyvinyl alcohol (PVA) as stabilizing and capping agents. Excellent antibacterial and anti-biofilm action against both gram-positive and gram-negative bacteria was shown by the resultant ZnO nanoparticles. The result of microwave-irradiation of silver salts, namely silver nitrate, are silver nanoparticles, which are a prime example of the adaptability and effectiveness of microwave-assisted synthesis in the creation of nanoparticles.¹⁰

Solegel method:

Metal oxides are produced by the solegel method from a chemical solution that serves as a precursor to discrete particles or a mixed polymer network. Solegel is a method used in material chemistry to create tiny particles. Precursor sol provides a flexible synthesis method: it can be poured onto a substrate to create a film that can be shaped into a desired shape container, or it can be used to create powder. The production of metal oxides is the main application for this technique. Discrete polymers or particles make up the gel composition; the most often used precursors are metal alkoxides and chlorides. In order to create colloidal particles, these precursors go through hydrolysis and poly-condensation. The hydrolysis of the alcoholic group and the condensation that follows are the main processes in the sol-gel process. A casting container that is appropriate can be used to form the obtained precursor sol into the desired shape. On the other hand, it can be deposited onto a substrate by spin or dip coating, film formation, or used to make microsphere or nanosphere powder. There are various steps involved in the sol-gel synthesis process, such as mixing, casting, gelation, aging, drying, and densification. This process works well for synthesizing a wide range of materials, especially metal oxides. It is also highly versatile.Solegel methods were effectively used to generate Fe3O4 nanoparticles, which were then annealed under vacuum at different temperatures. The solegel approach revealed that the morphological particles were nearly spherical.¹⁰

Plasma Assisted Chemical Vapors Deposition (PECVD):

A popular technique for thin film deposition is plasma-enhanced chemical vapor deposition (PECVD), which is very useful when making microelectronic circuits. This technique, known as Microwave Plasma-Enhanced Chemical Vapor Deposition (MPECVD), makes use of microwave plasma to aid chemical vapor deposition and was crucial in the production of gallium nitride nanoparticles. Carbon nanoparticles and hydrogenated silicon nanoparticles were created using microwave plasma enhanced chemical vapor deposition (MPECVD) and radio frequency plasma-enhanced chemical vapor deposition (RFPECVD), respectively. Researchers used PECVD methods to create hard, inflexible films made of carbon nanoparticles. Important steps in this process were using metal (or carbon) bilayer and multilayer designs, adjusting self-bias, and combining different doping strategies. A silica nanoparticle array was created on a flexible polymer substrate in 2012 using PECVD. But as power grew, the plasma's reactivity increased as well, resulting in a rise in chemical reactions and the creation of additional nuclei. Because of this circumstance, small-sized nanoparticles were able to develop by preventing coagulation growth. The ternary film TiO2-CNT-Ag (Titanium Dioxide-Carbon Nanotubes) was successfully synthesized using the improved chemical vapor deposition process by plasma. This technique demonstrates how PECVD can be used to create sophisticated materials with particular qualities, which can be applied to a variety of nanotechnology applications.¹⁰

Solvothermal synthesis:

A flexible method for producing a variety of nanoparticles with a precise and narrow size distribution is solvothermal synthesis. In contrast to the hydrothermal method, the solvothermal methodology allows for the use of different solvents and broadens its usefulness beyond water-based solvents. This process works well for creating nanoparticles and nanorods with or without the addition of surfactants because it provides more control over the shape, size, and crystallinity distributions than hydrothermal methods do. Tri-ethylene glycol was used to effectively create CuFe2O4 nanoparticles in a noteworthy solvothermal technique application. Tri-ethylene glycol is a multifunctional agent that functions as a reductant, stabilizer, and solvent. Moreover, MgMn2O4 spinel nanoparticles were produced using a reductive solvothermal technique, indicating the potential of spinel oxide as a cathode material because of its high theoretical energy density and comparatively high Mg-ion diffusivity. Furthermore, the solvothermal procedure demonstrated to be a simple technique for low-temperature synthesis of pure nickel nanoparticles. This demonstrates how versatile and effective solvothermal synthesis is at creating nanoparticles with specific properties for a range of uses.¹⁰

Polyol synthesis:

Originally designed to produce noble metal particles, polyol synthesis has expanded to include the synthesis of magnetic nanoparticles. In this process, polyethylene glycol serves as a solvent, complexing agent, and reducing agent while a metal-containing chemical is used in a reaction medium. The metal precursor is dissolved in a polyol solution and heated to almost freezing temperatures in the polyol process. The polyol's function as a reducing agent for metal reduction in the reactions is facilitated by the high temperatures. The polyol approach is noteworthy for its scalability, which enables the bulk manufacture of nanoparticles. Using the polyol approach, magnetic nanoparticles, including magnetite (Fe3O4), and other materials have been effectively produced at low temperatures. A variety of nanoparticles, such as metal oxide NPs, metal hybrid NPs, metal-based NPs, and magnetic NPs, have been produced using this adaptable technique. Researchers created a variety of nanostructures in 2019 and examined their antibacterial properties against harmful germs using the polyol-mediated synthesis technique. The size of the nanoparticles showed an inverse association with the antibacterial activity. Moreover, polyols demonstrated the versatility and efficiency of the polyol synthesis process by acting as the reductant and solvent in the production of various CuInS2 (CIS) nanostructures.¹⁰

Micro Emulsion Technique:

The micro-emulsion method was successfully used to create inorganic nanoparticles. The reduction strategy, when combined with the microemulsion method, made the process of manufacturing metal nanoparticles simple. This method yields a wide range of inorganic nanomaterials, including magnetic nanoparticles, metal oxide nanoparticles, semi-conducting metal sulphites nanoparticles, composite nanoparticles, and metal salt nanoparticles. Microemulsions are a suitable medium for dispersing substances because of their macroscopic uniformity, optical transparency, isotropy, and thermal stability. The microemulsion system consists of monodispersed, usually spherical, water-in-oil or oil-in-water droplets, depending on the surfactant used. Using this technique, researchers reported producing Pt cubic nanoparticles quickly and easily. Using a microemulsion technique and a water-to-surfactant ratio of 5, zinc oxide nanoparticles were created, displaying their wurtzite structure. Although this approach produces well-crystallized nanoparticles, there are significant limitations to the type, size, and form of nanoparticles that can be produced. Tween-80 and SDS (Sodium dodecyl) surfactants were crucial in the production of magnetite and silica-coated nanoparticles in water-in-oil microemulsions. By adopting the microemulsion process, stable SiO2 nanoparticles of different sizes were successfully produced. Moreover, the calcination process in conjunction with the reverse microemulsion technique shown efficacy in producing BiVO4 nanoparticles. This demonstrates the wide range of uses and flexibility of the micro-emulsion method for creating inorganic nanoparticles.¹⁰

Biological method:

The biological pathway encompasses several techniques, such as fungus, algae, bacteria, yeast, and so on. In many respects, biogenic enzymatic nanoparticles are far superior to chemically produced nanoparticles. The latter technologies, while capable of producing vast quantities of NPs with a specified size and shape in a short period of time, are inefficient, costly, antiquated, and complicated. They also produce hazardous toxic wastes that are detrimental to human health as well as the environment.⁹

4.3.1 Preparation of nanoparticles using Fungi:

Nanoparticles can be produced through a unique process involving the use of fungi. Among microbial entities, fungi stand out as a predominant group, finding applications across diverse scientific fields like bioremediation, enzyme synthesis, and nanotechnology. Notably, fungi exhibit distinct advantages over bacteria in synthesizing metallic nanoparticles, attributed to their scalability, efficient downstream processing, economic viability, and the expansive surface area facilitated by their mycelial structure. The process relies on a biomineralization mechanism inherent to fungi, employing a combination of internal and extracellular enzymes and biomolecules to reduce different metal ions. Moreover, Au, Se, Ti, Cu, and Zn stand out as prominent metal ions utilized by fungi for nanoparticle production. Diverse investigations into NP biosynthesis have focused on a range of fungi species, including Fusarium, Aspergillus, Trichoderma, Verticillium, Rhizopus, and Penicillium. Noteworthy examples include Aspergillus sp. generating Au-NPs and Fusarium strain producing Ag-NPs. Fungi, such as F. oxysporum and Verticillium sp., have been observed to produce magnetite NPs, a magnetic iron oxide (Fe3O4). Fungal-derived nanoparticles find applications in medicine, anticancer drugs, antimicrobials, antibiotics, antivirals, diagnostics, antifungals, engineering, biosensors, agriculture, bioimaging, and industry. The predominant uses are identified in agriculture and medicine, where fungi, compared to bacteria, exhibit a remarkable capacity to secrete proteins, leading to an enhanced nanoparticle output.⁹

Preparation of nanoparticles using yeast:

Nanoparticle creation via yeast is an innovative method. Researchers harnessed a silver-tolerant yeast strain called MKY3 through a process involving silver nitrate. Under specific environmental conditions, these yeast cells facilitate the formation of Ag-NPs. Interestingly, different yeast strains generate nanoparticles in distinct ways, resulting in variations in size, distribution, and properties of the particles. The molecules involved in this process dictate how the nanoparticles form and stabilize within the diverse yeast species examined. This process also showcases the yeast cells' ability to transform metal ions into non-toxic compounds, a mechanism crucial for their resistance. Utilizing yeast for mass-producing metal nanoparticles offers several advantages, including easy management in laboratory settings, rapid growth, and their capacity to thrive on basic nutrients. Candida glabrata and Saccharomyces pombe yeast strains are known for their ability to generate nanoparticles such as silver, cadmium sulfide, titanium, selenium, and gold through intracellular synthesis, serving specific purposes.⁹

Preparation of nanoparticles using bacteria:

Exploration has predominantly centered around prokaryotic organisms in the creation of metallic nanoparticles. These microorganisms, widely distributed in the environment and adept at surviving challenging conditions, prove conducive to scientific investigation. Their rapid growth, cost-effectiveness in cultivation, and ease of handling make them particularly amenable for study. It is simple to adjust development parameters including temperature, oxygen saturation, and incubation period. It is demonstrated that bacteria are able to synthesis inorganic materials externally or inside their cells. For instance, microorganisms are used in the bioreduction process to create Ag-NPs. Microorganisms manufacture extra-reductase enzymes that decrease metal ions to nanoscale ranges. The bioreduction of silver ions to silver nanoparticles is facilitated by the NADH-dependent reductase enzyme, as per a protein assay conducted on bacteria. After NADH is oxidized to NAD+, the reductase enzyme uses its electrons from NADH. Ag+ is reduced to Ag-NPs in the concurrent process, which causes the enzyme to oxidize. The bacteria Pseudomonas stutzeri was used to produce Ag-NPs outside of the cell. In addition, many strains of bacteria, both Gram-positive and Gram-negative, such as A. calcoaceticus, B. amyloliquefaciens, B. flexus, B. megaterium, and S. aureus, have been employed for the production of Ag-NPs that take place both inside and outside of the cells. Ag-NPs in a variety of shapes, including spherical, disc-shaped, cuboidal, hexagonal, and triangular, were prepared from cells, aqueous cell-free extracts, or culture supernatant. Furthermore, Rhodopseudomonas capsulata has been shown to produce Au-NPs in a range of sizes, with pH levels having an impact on the Au-NPs' shape. Potential biofactories for producing metal nanoparticles such as selenium, silver, palladium, gold, platinum, titanium, magnetite, titanium dioxide, cadmium sulfide, and other metal nanoparticles are thought to be bacteria.⁹

Preparation of nanoparticles using actinomycetes:

The ability of actinomycetes to produce antibiotics as secondary metabolites makes them a valuable material for the manufacture of nanoparticles. A significant portion of metal nanoparticle production is attributed to actinomycetes. It has been shown that a variety of organisms, including bacteria, fungi, algae, actinomycetes, plants, and others, are capable of producing metal nanoparticles through biogenesis. Actinomycetes are recognized as promising microbes for the intracellular and extracellular creation of metal nanoparticles, despite their relative lack of research. These microbes produce nanoparticles with strong biocidal action against a variety of illnesses, excellent polydispersity, and stability. Au-NPs have been successfully produced by certain species of bacteria, including Thermoactinomycete sp., Rhodococcus sp., Streptomyces viridogens, Nocardiafarcinica, Streptomyces hygroscopicus, and Thermomonospora sp. On the other hand, Streptomyces species have been successfully used to make Cu-NPs, Ag-NPs, Mn-NPs, and Zn-NPs.⁹

Preparation of nanoparticles using the plant:

Plant parts that have been successfully used in the creation of nanoparticles include leaves, stems, roots, shoots, flowers, barks, seeds, and the metabolites that are linked with these parts. Plants offer sophisticated and beneficial properties for human uses, and they are highly eco-friendly and low-cost. The green production of Pd-NPs and Pt-NPs has been clarified by using plant extracts from species like Pinus resinosa, Cinnamomum camphora, Ocimun sanctum, Anogeissus latifolia, Curcuma longa, Musa paradisica, Pulicariaglutinosa, Glycine max, Doipyros kaki, and Gardenia jasminoides. Zinc oxide from zinc nitrate and zinc acetate, silver from silver nitrate, gold from gold chloride, cadmium sulfide, zinc sulfide from cadmium sulfate and zinc sulfate, and several other nanoparticles have been produced from a variety of plants and their constituent parts. There have been reports recently of Ag-NPs produced from Pongamiapinnata seed extract in an environmentally friendly manner. An absorption peak at 439 nm provided validation for the formation of nanoparticles. With an average size of 16.4 nm, these well-dispersed nanoparticles showed a zeta potential of 23.7 mV, which suggests stability and dispersion. Additionally, the study of the interaction between Au-NPs and human serum albumin revealed no discernible effect on the helical shape of the albumin.⁹

5. Characterisation and Evaluation

v  Particle size and shape :

Particle shape and size distribution are the two most important aspects of nanoparticle characterization. Size and morphological measurements are made via electron microscopy.
The main applications of nanoparticles are in medication delivery and targeting. Particle size has been shown to affect medication release. Smaller particles provide larger surface areas. As a result, most of the medication that has been applied to them will be exposed to the surface of the particles, leading to quick drug release. On the other hand, drugs disperse more slowly through larger particles.¹⁵

The nanoparticles' diameters, which varied according to the polymer load, were measured using a scanning electron microscope and ranged from 350 nm to 600 nm.¹⁶

v Surface hydrophobicity:

The hydrophobicity of a surface can be determined using a variety of techniques, such as hydrophobic interaction chromatography, biphasic partitioning adsorption of probes, and contact angle measurements. Many sophisticated analytical techniques for studying nanoparticle surfaces have recently been reported in the literature. Specific chemical groups on the surface of nanoparticles can be identified by means of X-ray photon correlation spectroscopy.¹⁵

v Polydisperse index:

Another name for PDI is particle size distribution. Photon correlation spectroscopy is used to determine the polydisperse index value >0.7.1 PDI of nanoparticles in samples with a very broad size distribution. If the chain length varies greatly throughout a broad range of molecular mass, polydisperse is made up of non-uniform molecular mass. The goal of the manufacturer's nanoparticle formulation process is to obtain the lowest possible polydisperse index.¹⁴

v Zeta potential:

A common measure used to describe the surface charge of nanoparticles is the Zeta potential. This value, which is dependent on the makeup of the particle and the surrounding medium, reflects the electrical potential of particles. When a nanoparticle's zeta potential is greater than (±) 30 mV, it indicates that the surface charge prevents the particles from aggregating.¹³

v Determination of percentage drug entrapments efficacy:

10 ml of pure water was mixed with precisely weighed nanoparticles (10 mg) in order to measure the encapsulation efficiency. After centrifugation, the clear supernatant was filtered once equilibrium solubility was reached. Next, 4 ml of methanolic HCl was mixed with 1 ml of the filtrate. An analysis was performed on the resultant sample at 275 nm using a UV-visible spectrophotometer. The formula was used to get the encapsulation efficiency.¹²

Encapsulation efficiency (%) = [1 - (Amount of drug in supernatant / Total amount of drug added)] x 100

v Scanning electron microscopy:

However, the manufactured drug nanoparticles and the raw drug's particle morphology were examined using scanning electron microscopy. A small portion of each drug powder sample was coated with a Pt–Pd alloy about 5 nanometers thick after being mounted on a double-sided conductive carbon strip. Using a Zeiss DSM 982 Field Emission Gun Scanning Electron Microscope, micrographs were captured.¹²

v X ray diffraction study:

An XRD-6000 diffractometer was used for the X-ray diffraction analysis. The pure drug's and the formulation's crystallinity were found using X-ray diffraction examination. The powder was put inside a sample holder made of aluminum. Cu radiation was produced at 40 kV and 30 mA. As previously mentioned, samples were scanned at a range of 10° to 90° at a scan speed of 10° min-1.¹⁶

v Fourier Transform Infrared Spectroscopic analysis (FT-IR):

To look into any interactions between the drug and polymers in the formed nanoparticles, the FT-IR Spectrophotometer was used to record the FT-IR spectra of the drug and polymers in the polymeric nanoparticles. With a specific resolution, the synthesized formulation was scanned over the desire wavelength .¹⁷

v Differential scanning calorimetry ( DSC):

DSC research was carried out to ascertain the physical state of the original medication within the nanoparticles. The natural medication, polymer, and nanoparticles were each added to separate, sealed, standard aluminum pans containing about 2 mg of each. Then, in a nitrogen environment, these pans were scanned over a temperature range of 25°C to 300°C at a heating rate of 10°C/min. In the analysis, an empty aluminum pan served as the reference.¹¹

APPLICATION

Nanotechnologies' prospective uses in medicine are still developing and showing promise in a number of fields. Their use in molecular imaging, targeted medication delivery, illness diagnostics, detection, and medical device applications is the subject of ongoing research. Furthermore, nanomaterials are specifically used as biomarkers, which are used to identify and produce a unique "contrast" at particular locations within the human body. This facilitates processes such as imaging and component identification in samples taken from the human body.¹

v  Nanobots:

The remarkable engineering achievement of nanobots is among the most significant uses of nanotechnology in medicine. As the name implies, nanobots are tiny surgical helpers that can be employed to replace intracellular structures in the human body or repair damaged cells. They are being created with the ability to replicate in order to replace certain molecules to eradicate diseases from the human body or to cure a genetic deficit.¹

v  Nanoparticles for In-Vivo Imaging:

Because of their nature and the ease with which they can move throughout the human body, nanoparticles are playing a key role in producing the high-resolution, high-contrast images required for precise diagnostics and imaging. Due to their very dependable imaging results and their ability to be designed and used with flexibility, nanomaterials are becoming increasingly important in the field of imaging. By adhering to certain diseased cells in the human body and serving as contrast agents for imaging, nanomaterials help doctors distinguish between healthy and diseased cells.¹

v  Fluorescent Markers:

In the human body, nanoparticles allow for the use of fluorescent markers for imaging, diagnosis, and screening even for distant tissues and organs. Through the attachment of quantum dots to specific molecules, nanotechnologies provide the opportunity for intracellular imaging, which is being used to analyze and diagnose human body samples in order to detect changes at the molecular level as well as potential biological markers. Because they facilitate in the processes of detection and prevention, these nanoparticles are referred to as nanotools. Greater potential for increasing diagnostic precision is made possible by this. These nanoparticles can be designed to perform a variety of tasks on their own, including drug delivery to aid in the course of treatment and diagnosis. They can even be left at the intended location to track development.¹

v  Nanotherapeutics for Cardiovascular Health:

Targeted drug administration within the cardiovascular system of humans is challenging due to its complexity, making it difficult to obtain accurate diagnosis and imaging. In order to increase the effectiveness of nano therapeutics in the treatment of inflammatory and cardiovascular disorders, strategies for leveraging the special qualities of nanoparticles to facilitate targeted drug delivery are being proposed. To treat cardiovascular disorders, nanoparticles can be used, but a key challenge is still establishing adequate and heterogeneous delivery.¹

Nanotechnology in Regenerative Medicine In the quickly evolving field of life sciences known as "stem cell technology," human body stem cells are used as progenitors that can self-renew and differentiate, allowing for in-vitro manipulation and the replacement of damaged cells in the body to treat illnesses. The fusion of nanotechnology and stem cell technologies has given rise to a novel area of medicine called regenerative medicine. For instance, tissue engineering and regenerative medicine can employ nano diamond polymer composites to repair injured tissue. Likewise, several bioengineered nanoparticles are being investigated for their potential to regenerate bone.¹

v  Nanoparticles in Cancer therapy:

While nanoparticles are being developed to treat a wide range of illnesses, the focus on cancer detection and treatment continues to be a significant advancement in this field. The five-step "CAPIR" medication delivery procedure for cancer treatment involves circulating the nanoparticle in blood, allowing it to accumulate, then penetrating the cancer tumor. Internalization inside the cell and medication release via nanoparticle application come next. The quick commencement of effective therapeutic activity is facilitated by the nanometals, which improve medication solubility and adherence to targeted tumor surfaces. Because they can be actively or passively targeted to cancer tissues to enhance anticancer drug delivery and hence minimize severe side effects, drug-loaded delivery vehicles or nanoparticles are appealing. Another strategy being investigated is the use of nanoparticles to combine multiple medications into a single carrier to solve the issue of inadequate drug delivery brought about by the application of modern medicine and the requirement for improvement. Additionally, this might make it possible to target many tumors for improved cancer diagnosis and treatment.¹

v  Nano devices for Diagnosis:

The nanomaterial presents a huge opportunity for advancement as a modern diagnostic instrument. A more sensitive and precise molecular probe and biosensor that facilitates diagnosis can be created by utilizing a nanoscale device or nanomaterials that have the potential to directly interact with the biological system at the subcellular and molecular level. For instance, several businesses are working on creating microchips that can detect the dielectric characteristics of bacteria, viruses, and malignant cells in bodily fluids using electrodes.¹

v  Pulmonary drug delivery:

Because of the deep-seated nature of microorganisms in the airways and the possibility of antibiotic resistance, treating respiratory infections is a challenging undertaking. For nanomedicine, successfully delivering medications to these deeper portions of the airway system is a major future milestone. This difficulty may be addressed by the unique nanoparticles, which exhibit promise in surmounting biological barriers within the human body.¹

v  Controlled Response systems:

Researchers have expressed worries about the toxicity and drug release of nanoparticles used in drug delivery in the human body. However, it is possible to build nanoparticles to permit sustained release systems within the body.Because the nanoparticles are designed to release the drug in reaction to certain stimuli, more study is currently being done on this strategy in hopes of applying it to medicine.¹

v  Nanomedicine in Public Health:

With the progress being made in the field of nanomedicine, there is a great deal of promise for improving public health in a number of ways, including enhancing longevity, promoting general health, treating and avoiding disease conditions, and curing life-threatening illnesses. Additionally, it can help with concerns related to social or community health, such as early identification and prevention of infectious diseases, civic sanitization, immunization, and environmental infection management.¹

OBSTACLES IN THE DEVELOPMENT OF PHARMACEUTICAL NANOMEDICINES:

Over the past two decades, pharmaceutical nanotechnology has undergone significant growth and advancement. A particular focus has centered on nanomedicine, holding the promise of transforming medical treatment by offering more effective, less harmful, and targeted therapies for various diseases. While several nanomedicines have emerged and gained approval for clinical application, their development has demanded substantial effort from both academic and biopharmaceutical sectors. Yet, nanomedicine remains in its early stages, with limited success stories, primarily due to various challenges encountered in its development. These challenges encompass hurdles in drug delivery across diverse biological barriers and complications in formulating, characterizing, and manufacturing nanomedicines.⁸

FUTURE OPPORTUNITIES

The majority of uses are either in the hypothesis stage or are still being researched and tested on animals. By coating the surfaces of nanoparticles with red cell membranes instead of PEG, creating nanoparticles with different ligands, drug particles, and shapes, as well as by using photosensitive agents that accumulate in tumors, increasing the porosity of blood vessels to allow for the penetration of nanoparticles, attaching RNA to treat skin cancers, and creating monoclonal antibodies and vaccines targeted against tumors, researchers are trying to increase the blood circulation of nanoparticles. DDS based on nanotechnology may enhance future advances in gene treatment, anticancer therapy, and radiation.

Multifunctional nanoparticles have the ability to identify cancerous cells, deliver several drugs at once, use imaging agents to pinpoint the location, destroy cancer cells with minimal to no side effects, and simultaneously monitor and treat patients. Nanoparticles will play a major role in robotic surgery. Together with nanoparticles, computer programs can be utilized to automatically control homeostasis in relation to variables like serum calcium and blood glucose levels. Nanoparticles in immunology have the capacity to function as effective defenses against invading particles.¹⁹

When it comes to the distribution, release, and targeting of medications, nanoparticles are quite advantageous. They are among the most crucial instruments in nanomedicine because of their capacity to integrate therapy and diagnostics. Improving drug loading, targeting, transport, release, and interaction with biological barriers are the main goals. They also involve the biodistribution of active ingredients through mediation. It is still a major problem because nanoparticles or the products of their disintegration are cytotoxic, and future studies will surely concentrate on methods to make them more biocompatible.²⁰

CONCLUSION

This study gives a general review of Nanopharmaceutical and Nanotechnology used in the formulation. Drugs that are poorly soluble in water and pass through the liver can be delivered using a system based on nanotechnology, preventing them from being metabolised in the first path. It might make a medication more bioavailable. Nanoparticles are appropriate for the various administration routes discussed above. In comparison to other components, nanoparticles are safe for the manufacture of novel medicines. The primary benefit of a nanotechnology-based drug delivery system is that it allows for precise drug targeting and controlled drug release. Because of the multiple solvents utilized in the manufacturing, the nanoparticles moderate the toxicity and trigger allergic reactions and immunological responses in the body. The vision of the future of medicine will be nanomedicine, which will use nano-based drug delivery systems. The discovery of new drugs and discoveries related to disease treatment have a significant impact on Nanopharmaceutical systems.

ACKNOWLEDGMENT

We are thankfull to principal and management of Ali Allana College of Pharmacy Akkalkuwa for providing all necessary facilities during this study.

REFERENCES

1.      Nanomedicine: De-coding nano-regulation in India and considerations for the future. Nishith Desai Associates, July 2022.

2.      Dr. Shruthi Chandrasekaran And Dr Jaideep Mahendra. Good Things In Small Packages: Nanoperiodontics - A Comprehensive Review. International Journal Of Recent Scientific Research Vol. 11, Issue, 06 (E), June, 2020 Pp. 39061-39067.

3.      Nanopharmaceuticals: Guidelines for Evaluation of Nanopharmaceuticals in India. Directorate General of Health Services, Central Drugs Standard Control Organization, New Delhi. March 7, 2019.

4.      Department of Biotechnology, Ministry of Science & Technology, Government of India, Central Drugs Standard Control Organization, Ministry of Health & Family Welfare, Indian Council for Medical Research. Guidelines for Evaluation of Nanopharmaceuticals in India. New Delhi: Government of India; October 2019.

5.      Verma Surender And Makkar Deepika. Solid Lipid Nanoparticles: a Comprehensive Review. Journal Of Chemical And Pharmaceutical Research, 2016, 8(8):102-114.

6.      Ahmed A. H. Abdellatif, Hamdoon A. Mohammed, Riaz A. Khan, Varsha Singh, Abdellatif Bouazzaoui, Mohammad Yusuf, Etal. Nano-Scale Delivery: A Comprehensive Review Of Nano-Structured Devices, Preparative Techniques, Site-Specificity Designs, Biomedical Applications, Commercial Products, And References To Safety, Cellular Uptake, And Organ Toxicity. Nanotechnology Reviews 2021; 10: 1493–1559.

7.      Serjay Sim And Nyet Kui Wong. Nanotechnology And Its Use In Imaging And Drug Delivery (Review). Biomedical Reports 14: 42, 2021.

8.      Hawraz Jawdat Jaafar. The Importance Of Nanopharmaceuticals And Nanomedicines Applications And Properties: A Current Review. Technium Biochem med Vol. 5, 2023 .1-29.

9.      Salem S. Salem, Eman N. Hammad, Asem A. Mohamed , Wagdi El-Dougdoug . A Comprehensive Review Of Nanomaterials: Types, Synthesis, Characterization, And Applications. Volume 13, Issue 1, 2023, 1-30.

10.  Swati Kumari , Sakshi Raturi , Saurabh Kulshrestha , Kartik Chauhan ,Sunil Dhingra , Kovacs Andras. A Comprehensive Review On Various Techniques Used For Synthesizing Nanoparticles. Journal Of Materials Research And Technology 2023;27: 1739 -1763.

11.  Ankita Pokhriyal, Geetika Tripathi. Evaluation Parameters Of Nanoparticles: A Review . Indian Journal Of Novel Drug Delivery 14(3), Jul-Sep, 2022, 138-142.

12.  V. Swapna, K. Siva Divya , Nb. Pati1 , B. Ravindra Babu1 And A. Lakshmana Rao. Preparation And Evaluation Of Lamivudine Nanoparticles. Ijrpc 2019, 9(3), 154-160.

13.  Dr. Meenakshi Munjal. Nanoparticles - Preparation, Technology, Evaluation And Used In Targeted Drug Delivery System. The Pharma Innovation Journal 2018; 7(11): 373-377.

14.  Mahesh Gajanan Umbarkar, Pooja Sudhakar Rindh , Shivkanya Sanjay Chandrawanshi, Manoj J. Chavan4, Vijay Manaskar .Formulation And Evaluation Of Polymeric Nanoparticle By Nano-Precipitation Method. Journal Of Drug Delivery & Therapeutics. 2020; 10(5-s):136-142.

15.  Muni Raja Lakshmi K, Lavanya E, Naseema Shaik, Vankata Rao Gadde Formulation And Evaluation Of Nanoparticles-A Review. International Journal In Pharmaceutical Sciences,2023, Vol 1, Issue 7, 196-204.

16.  Ankita Pokhriyal, Geetika Tripathi. Evaluation Parameters Of Nanoparticles. Scholars Research Library Der Pharmacia , 2022, 14 (3): 24-29.

17.  Abdul Hasan Sathali A, Manikkavasagan A, Umamaheswari D, Prabhu R (2022). Formulation And Evaluation Of Polymeric Nanoparticles Of Felodipine. Saudi J Med Pharm Sci, 8(2): 38-47.

18.  Abuzer Alp Yetisgin , Sibel Cetinel, Merve Zuvin, Ali Kosar and Ozlem Kutlu. Therapeutic Nanoparticles and Their Targeted Delivery Applications. Molecules 2020, 1-31.

19.  Chamindri Witharana And Janith Wanigasekara .Drug Delivery Systems: A New Frontier In Nano-Technology. International Journal Of Medical Research & Health Sciences, 2017, 6(9): 11 – 14.

20.  Sovan Lal Pal, Utpal Jana, P. K. Manna, G. P. Mohanta, R. Manavalan. Nanoparticle: An Overview Of Preparation And Characterization. Journal Of Applied Pharmaceutical Science 01 (06); 2011: 228-234.